Suraksha Pharma Private Limited
| Private | |
| ISIN | 🆔 |
| Industry | Pharmaceuticals |
| Founded 📆 | May 8, 1998 |
| Founder 👔 | |
Area served 🗺️ | |
Key people |
|
| Products 📟 |
|
| Members | |
Number of employees | |
| 🌐 Website | surakshapharma |
| 📇 Address | |
| 📞 telephone | |
Suraksha Pharma Private Limited is an Indian pharmaceutical manufacturing company headquartered in Hyderabad, Telangana, India.[1] The company was established on 8 May 1998 and is involved in the development, manufacturing, and distribution of pharmaceutical formulations, nutraceuticals, and cosmetics.[2]
History
Suraksha Pharma was incorporated on 8 May 1998 under the Companies Act, 1956.[3] It is registered with the Registrar of Companies (ROC), Hyderabad, and holds the Corporate Identification Number (CIN) U24230TG1998PTC029377.[4]
Management
The company is managed by a board of directors:
- Nageswararao Gupta Manepalli – Managing Director (since 2003)[5]
- Someswara Rao Manepalli – Whole-time Director (since 2006)[6]
- Padmaja Rani Manepalli – Whole-time Director (since 2016)[6]
- Raghva Tayaru Aswani Manepalli – Whole-time Director (since 2019)[6]
Financials
Suraksha Pharma has an authorized capital of ₹10 crore and a paid-up capital of ₹6.05 crore.[1] For the financial year ending March 2023, the company reported operating revenue between ₹1 crore and ₹100 crore, with an EBITDA growth of 35.76% year-on-year.[7]
Products and Services
Therapeutic Categories
Suraksha Pharma manufactures a wide range of formulations across therapeutic areas:[8]
- Anti-ulcer medications
- Analgesics and antipyretics
- Antibiotics and anti-infectives
- Neuropsychiatric medicines
- Anti-allergic drugs
- Cardiac care products
- Diabetic medications
- Nutraceuticals and antioxidants
Brands and Dosage Forms
The company markets over 50 brands, including Amsha, Arol, Dutix, and Gliprip. Products are available in:
- Tablets
- Capsules
- Dry syrups
- External preparations
Manufacturing
Suraksha Pharma's main manufacturing unit is located in Hyderabad.[9] It also operates a research and analytical laboratory in Roorkee, Uttarakhand.[10] The Roorkee facility is 20,000 square feet in size and is GLP compliant, Schedule-M certified, and working towards WHO-cGMP certification.
Production Capacity
- Tablets: 30 million units/month
- Capsules: 10 million units/month
- Dry syrups: 50,000 bottles/month[11]
Certifications
The company holds the following certifications:[12]
- ISO certification
- GMP certification
- FSSAI license
- Form-26 license
- NHP Canada approval
Exports
Suraksha Pharma exports to more than 30 countries across Asia, Africa, North America, and the CIS region.[13] It has completed over 1,800 international shipments to 48 buyers.
Key Export Markets
- Canada
- Kenya
- Myanmar
- United States
Exports are mainly classified under:
- HSN Code 3004 – Medicaments in finished form
- HSN Code 3003 – Bulk medicaments
Group Companies
Suraksha Pharma is part of the Suraksha Group, which includes:[14]
- MMC Health Care Limited
- Surax Healthcare Private Limited
- Surax Cosmetics Private Limited
- Hemp Tribe Private Limited
- Scoat Pharma Private Limited
- Sumages Pharma Private Limited
- Roorkee Research & Analytical Labs Private Limited
It also operates international subsidiaries such as Suraksha Natural Inc, Suraksha Pharma Inc, and Surax Healthcare Inc in the United States.[1]
Contract Manufacturing
The company provides:
- Solid and non-sterile dosage forms
- Packaging solutions
- Regulatory assistance[15]
It has over 60 contract manufacturing clients and an in-house foil manufacturing facility.[11]
Awards and Recognition
Suraksha Pharma and its leadership have received several awards:[12]
- Best Entrepreneur Award
- Women Glory Award
- Hall of Fame Award
- Power Women Award
- Women Entrepreneur Award
Future Plans
Suraksha Pharma is pursuing WHO-cGMP certification for its R\&D facility and aims to expand into parenteral (injectable) manufacturing.[10] The company reports an annual growth rate of 60% and is focused on expanding its global footprint and developing complex formulations.
References
- ↑ 1.0 1.1 1.2 [1](https://www.tofler.in/suraksha-pharma-private-limited/company/U24230TG1998PTC029377)
- ↑ [2](https://www.emis.com/php/company-profile/IN/Suraksha_Pharma_Private_Limited_en_6340178.html)
- ↑ [3](https://www.filesure.in/company/suraksha-pharma-private-limited/U24230TG1998PTC029377?tab=about)
- ↑ [4](https://www.thecompanycheck.com/org/suraksha-pharma-pvt-ltd/a6ef3318ed)
- ↑ [5](https://in.linkedin.com/in/nageswara-gupta-manepalli-3960a178)
- ↑ 6.0 6.1 6.2 [6](https://www.indiafilings.com/search/suraksha-pharma-private-limited-cin-U24230TG1998PTC029377)
- ↑ [7](https://www.thecompanycheck.com/company/suraksha-pharma-private-limited/U24230TG1998PTC029377)
- ↑ [8](https://www.indiamart.com/surakshapharma/product-portfolio.html)
- ↑ [9](https://www.indiamart.com/surakshapharma/about-us.html)
- ↑ 10.0 10.1 [10](http://test.pharmabiz.com/news/suraksha-pharma-to-start-analytical-research-lab-in-roorkee-39470)
- ↑ 11.0 11.1 [11](https://www.indiamart.com/surakshapharma/infrastructure.html)
- ↑ 12.0 12.1 [12](https://www.globallinker.com/seller/suraksha-pharma-pvt-ltd-1)
- ↑ [13](https://www.volza.com/company-profile/suraksha-pharma-pvt-ltd-1969172/)
- ↑ [14](http://scoatpharma.com/screens/aboutUs.html)
- ↑ [15](https://pharmasource.global/directory/suraksha-pharma-pvt-ltd/)
This article "Suraksha Pharma" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Suraksha Pharma. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
